McCollum, S.; Kalivas, A.; Kirkham, M.; Kunz, K.; Okojie, J.; Pavek, A.; Barrott, J.
Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma. Pharmaceuticals 2022, 15, 650.
https://doi.org/10.3390/ph15060650
AMA Style
McCollum S, Kalivas A, Kirkham M, Kunz K, Okojie J, Pavek A, Barrott J.
Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma. Pharmaceuticals. 2022; 15(6):650.
https://doi.org/10.3390/ph15060650
Chicago/Turabian Style
McCollum, Sarah, Austen Kalivas, Matthew Kirkham, Kaden Kunz, Jeffrey Okojie, Adriene Pavek, and Jared Barrott.
2022. "Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma" Pharmaceuticals 15, no. 6: 650.
https://doi.org/10.3390/ph15060650
APA Style
McCollum, S., Kalivas, A., Kirkham, M., Kunz, K., Okojie, J., Pavek, A., & Barrott, J.
(2022). Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma. Pharmaceuticals, 15(6), 650.
https://doi.org/10.3390/ph15060650